Moreover, HCQ was revealed to be effective in preclinical and clinical trials to dampening autoimmune disease-dependent cardiovascular complications (Figure 7), as well as in the amelioration of disease-independent hyperglycemia, hyperlipidemia, and gastrointestinal complaints.